• 1
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
  • 2
    Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010; 7: 245-257.
  • 3
    Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999; 281: 1628-1631.
  • 4
    Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008; 14: 288-301.
  • 5
    Lipworth L, McLaughlin JK, Tarone RE, Blot WJ. Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev. 2011; 20: 331-333.
  • 6
    Brookman-Amissah S, Kendel F, Spivak I, et al. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma. BJU Int. 2008; 103: 1375-1380.
  • 7
    Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Publication No. 07-6215. Bethesda, MD: National Institutes of Health; 2007.
  • 8
    Lee WK, Byun SS, Kim HH, et al. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study. Int J Urol. 2010; 17: 898-904.
  • 9
    Capitanio U, Cloutier V, Zini L, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int. 2008; 103: 1496-1500.
  • 10
    Leibovich BC, Lohse CM, Crispen P, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010; 183: 1309-1316.
  • 11
    Lee JH, Choi JW, Kim YS. The value of histologic subtyping on outcomes of clear cell and papillary renal cell carcinomas: a meta-analysis. Urology. 2010; 76: 889-894.
  • 12
    Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003; 27: 612-624.
  • 13
    Patard JJ, Leary E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2011; 23: 2763-2771.
  • 14
    Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N. Rate of renal cell carcinoma subtypes in different races. Int Braz J Urol. 2011; 37: 29-34.
  • 15
    Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol. 2008; 179: 1704-1708.
  • 16
    Berndt SI, Carter B, Schoenberg MP, Newschaffer CJ. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol. 2007; 25: 3589-3595.
  • 17
    Hellenthal NJ, Chamie K, Ramirez ML, deVere White RW. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. J Urol. 2009; 181: 1013-1019.
  • 18
    Tripathi R, Heilbrun LK, Jain V, Vaishampayan UN. Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma. Urology. 2006; 68: 296-301.
  • 19
    Zini L, Perrotte P, Capitanio U, et al. Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int. 2008; 103: 889-893.
  • 20
    Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology,3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 21
    Surveillance, Epidemiology, and End Results (SEER) Program ( SEER*Stat Database: Incidence - SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2010 Sub (1973-2008 varying) - Linked To County Attributes - Total U.S., 1969-2009 Counties. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2011 (updated 10/28/2011), based on the November 2010 submission.
  • 22
    Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. J Natl Cancer Inst Monogr. 1961; 6: 101-121.
  • 23
    Surveillance Research Program, National Cancer Institute SEER*Stat software, version 7.0.5 [computer program]. Bethesda, MD: National Cancer Institute; 2011.
  • 24
    Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol. 2010; 28: 311-317.
  • 25
    Patel SG, Penson DF, Pabla B, et al. National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol. 2012; 187: 816-821.
  • 26
    Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010; 303: 2143-2150.
  • 27
    Appel LJ, Wright JT, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010; 363: 918-929.
  • 28
    Colt JS, Schwartz K, Graubard BI, et al. Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology. 2011; 22: 797-804.
  • 29
    Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011; 58: 579-587.
  • 30
    Neuzillet Y, Tillou X, Mathieu R, et al. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol. 2011; 60: 366-373.
  • 31
    Pignot G, Elie C, Conquy S, et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology. 2007; 69: 230-235.
  • 32
    Shah JB, Margulis V. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma. Expert Rev Anticancer Ther. 2010; 10: 837-842.
  • 33
    Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 2010; 31: 1805-1812.
  • 34
    Chow WH, Devesa SS. Underreporting and misclassification of urinary tract cancer cases on death certificates. Epidemiology. 1996; 7: 517-520.